Abstract:1. One carbon metabolism includes folate cycle, methionine cycle and transsulphuration pathway. 2. One carbon metabolism affects tumour microenvironment and the expression of immune checkpoint. 3. One carbon metabolism contributes to predict the prognosis of patients with immunotherapy and drug discovery. Background One‐carbon (1C) metabolism is a metabolic network that plays essential roles in biological reactions. In 1C metabolism, a series of nutrients are used to fuel metabolic pathways, including nucleotide metabolism, amino acid metabolism, cellular redox defence and epigenetic maintenance. At present, 1C metabolism is considered the hallmark of cancer. The 1C units obtained from the metabolic pathways increase the proliferation rate of cancer cells. In addition, anticancer drugs, such as methotrexate, which target 1C metabolism, have long been used in the clinic. In terms of immunotherapy, 1C metabolism has been used to explore biomarkers connected with immunotherapy response and immune‐related adverse events in patients. Methods We collected numerous literatures to explain the roles of one‐carbon metabolism in cancer immunotherapy. Results In this review, we focus on the important pathways in 1C metabolism and the function of 1C metabolism enzymes in cancer immunotherapy. Then, we summarise the inhibitors acting on 1C metabolism and their potential application on cancer immunotherapy. Finally, we provide a viewpoint and conclusion regarding the opportunities and challenges of targeting 1C metabolism for cancer immunotherapy in clinical practicability in the future. Conclusion Targeting one‐carbon metabolism is useful for cancer immunotherapy.

One-carbon metabolism shapes T cell immunity in cancer

Targeting one‐carbon metabolism for cancer immunotherapy

Tracing the Diverse Paths of One-Carbon Metabolism in Cancer and Beyond

T-Cell Immunometabolism Against Cancer

Targeting T Cell Metabolism in the Tumor Microenvironment: an Anti-Cancer Therapeutic Strategy

Regulation of Metabolism Across Different Subsets of T Cells in Cancer.

Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer

Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity

Cellular metabolism regulates the differentiation and function of T-cell subsets

Impact of One-Carbon Metabolism-Driving Epitranscriptome as a Therapeutic Target for Gastrointestinal Cancer

Beyond the Warburg Effect: How Do Cancer Cells Regulate One-Carbon Metabolism?

T cell metabolic fitness in antitumor immunity

Metabolic gatekeepers: harnessing tumor-derived metabolites to optimize T cell-based immunotherapy efficacy in the tumor microenvironment

Targeting metabolism to enhance immunotherapy within tumor microenvironment

Metabolic interventions: A new insight into the cancer immunotherapy

The Pivotal Role of One-Carbon Metabolism in Neoplastic Progression During the Aging Process

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity

Metabolic Reprogramming of Immune Cells in the Tumor Microenvironment

Advances in reprogramming of energy metabolism in tumor T cells

The potential role of CMC1 as an immunometabolic checkpoint in T cell immunity